8 results on '"Rodríguez, Yhojan"'
Search Results
2. List of contributors
- Author
-
Akar-Ghibril, Nicole, primary, Ale, Hanadys, additional, Anaya, Juan-Manuel, additional, Anstey, Karen M., additional, Awasthi, Smita, additional, Baker, Mary Grace, additional, Chambliss, Jeffrey M., additional, Chang, Christopher, additional, Chen, Meng, additional, Cheung, Hei Lam Helena, additional, Chitty-Lopez, Maria, additional, Chrisant, Maryanne, additional, Chu, Ka Hou, additional, Cosme-Blanco, Wilfredo, additional, Daley, Aparna, additional, Dimitriades, Victoria R., additional, Dowden, Amy, additional, Elsayed-Ali, Omar, additional, Feuille, Elizabeth J., additional, Fonacier, Luz, additional, Freij, Joudeh B., additional, Fung, Maxwell A., additional, Gaytán, Armando Partida, additional, Ge, Xiang, additional, Gebba, Jennifer, additional, Ghaffari, Gisoo, additional, Golpanian, Rachel Shireen, additional, Hathaway, Kathleen, additional, Heimall, Jennifer, additional, Hein, Nina, additional, Herrera Guerra, Angel A., additional, Horton, Rachel K, additional, Huang, Ke, additional, Hwang, Samuel T., additional, Kennedy, David W., additional, Kleiner, Gary, additional, Kline, Ahnika, additional, Kobrynski, Lisa J., additional, Kostandy, Erini Nessim, additional, Kuruvilla, Merin, additional, Lachmann, Helen J., additional, Lam, Wai Ching, additional, Lee, Gerald B., additional, Lee, Joyce S., additional, Lee, Min J., additional, Lehman, Heather K., additional, Leiding, Jennifer W., additional, Lejeune, Stéphanie, additional, Leung, Nicki Y.H., additional, Leung, Patrick S.C., additional, Liburd, Kyndra, additional, Lipman, Zoe Morgan, additional, Lu, Qianjin, additional, Lugo Reyes, Saul O., additional, Lyons, Jonathan J., additional, Lyu, Aiping, additional, Makol, Richika, additional, Mawhirt, Stephanie L., additional, McGrath, Eric, additional, Medina, Renata, additional, Nadeau, Kari, additional, Nkamba, Iris, additional, Nomula, Kranthi, additional, Ong, Peck Y., additional, Oriel, Roxanne C., additional, Otani, Iris M., additional, Park, Young Hwan, additional, Patkar, Rasika, additional, Peet, Claire J., additional, Permaul, Perdita, additional, Phipatanakul, Wanda, additional, Poowuttikul, Pavadee, additional, Ramirez, Lourdes, additional, Ranganathan Ganakammal, S., additional, Restrepo, Lucas, additional, Rodriguez, Marlen, additional, Rodríguez, Yhojan, additional, Rose, Nevenda Velikova, additional, Rush, Nia, additional, Sabella, Colleen M., additional, Sandhu, Amandeep, additional, Sani, Sonam, additional, Secord, Elizabeth, additional, Seth, Divya, additional, Shao, Tihong, additional, Shenderov, Faina, additional, Shih, Jennifer, additional, Shu, Shang An, additional, Sicherer, Scott H., additional, Simpson, Jessica, additional, Squire, Jacqueline D., additional, Sriaroon, Panida, additional, Stern, Heather, additional, Summerfield, Daniel D., additional, Sun, JinLyu, additional, Sweis, Auddie M., additional, Tison, Katherine L., additional, Vadakal, Siena, additional, Valentini, Kelly, additional, Vanijcharoenkarn, Kristine, additional, Viqar, Sehrish, additional, Wai, Christine Y.Y., additional, Walkiewicz, M., additional, Walter, Jolan E., additional, Wang, Julie, additional, Wiers-Shamir, Kristina, additional, Winters, Jeffrey L., additional, Wu, Haijing, additional, Xirasagar, S., additional, Xu, Jennifer, additional, Yosipovitch, Gil, additional, Zerbe, Christa, additional, Zhong, Lidan Linda, additional, Zhou, Suqing, additional, and Zhou, Xiaoying, additional more...
- Published
- 2022
- Full Text
- View/download PDF
Catalog
3. Post-COVID syndrome. A case series and comprehensive review.
- Author
-
Anaya JM, Rojas M, Salinas ML, Rodríguez Y, Roa G, Lozano M, Rodríguez-Jiménez M, Montoya N, Zapata E, Monsalve DM, Acosta-Ampudia Y, and Ramírez-Santana C
- Subjects
- Adult, Female, Humans, Immunoglobulin G, Lung, Middle Aged, SARS-CoV-2, Antibodies, Viral, COVID-19
- Abstract
The existence of a variety of symptoms with a duration beyond the acute phase of COVID-19, is referred to as post-COVID syndrome (PCS). We aimed to report a series of patients with PCS attending a Post-COVID Unit and offer a comprehensive review on the topic. Adult patients with previously confirmed SARS-CoV-2 infection and PCS were systematically assessed through a semi-structured and validated survey. Total IgG, IgA and IgM serum antibodies to SARS-CoV-2 were evaluated by an electrochemiluminescence immunoassay. A systematic review of the literature and meta-analysis were conducted, following PRISMA guidelines. Univariate and multivariate methods were used to analyze data. Out of a total of 100 consecutive patients, 53 were women, the median of age was 49 years (IQR: 37.8-55.3), the median of post-COVID time after the first symptoms was 219 days (IQR: 143-258), and 65 patients were hospitalized during acute COVID-19. Musculoskeletal, digestive (i.e., diarrhea) and neurological symptoms including depression (by Zung scale) were the most frequent observed in PCS patients. A previous hospitalization was not associated with PCS manifestation. Arthralgia and diarrhea persisted in more than 40% of PCS patients. The median of anti-SARS-CoV-2 antibodies was 866.2 U/mL (IQR: 238.2-1681). Despite this variability, 98 patients were seropositive. Based on autonomic symptoms (by COMPASS 31) two clusters were obtained with different clinical characteristics. Levels of anti-SARS-CoV-2 antibodies were not different between clusters. A total of 40 articles (11,196 patients) were included in the meta-analysis. Fatigue/muscle weakness, dyspnea, pain and discomfort, anxiety/depression and impaired concentration were presented in more than 20% of patients reported. In conclusion, PCS is mainly characterized by musculoskeletal, pulmonary, digestive and neurological involvement including depression. PCS is independent of severity of acute illness and humoral response. Long-term antibody responses to SARS-CoV-2 infection and a high inter-individual variability were confirmed. Future studies should evaluate the mechanisms by which SARS-CoV-2 may cause PCS and the best therapeutic options., (Copyright © 2021 Elsevier B.V. All rights reserved.) more...
- Published
- 2021
- Full Text
- View/download PDF
4. Convalescent plasma in Covid-19: Possible mechanisms of action.
- Author
-
Rojas M, Rodríguez Y, Monsalve DM, Acosta-Ampudia Y, Camacho B, Gallo JE, Rojas-Villarraga A, Ramírez-Santana C, Díaz-Coronado JC, Manrique R, Mantilla RD, Shoenfeld Y, and Anaya JM
- Subjects
- Betacoronavirus, COVID-19, Clinical Trials as Topic, Coronavirus Infections immunology, Humans, Immunization, Passive, Lymphocytes immunology, Pandemics, Pneumonia, Viral immunology, Retrospective Studies, SARS-CoV-2, COVID-19 Serotherapy, Antibodies, Neutralizing therapeutic use, Coronavirus Infections therapy, Pneumonia, Viral therapy
- Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible of the coronavirus disease 2019 (COVID-19) pandemic. Therapeutic options including antimalarials, antivirals, and vaccines are under study. Meanwhile the current pandemic has called attention over old therapeutic tools to treat infectious diseases. Convalescent plasma (CP) constitutes the first option in the current situation, since it has been successfully used in other coronaviruses outbreaks. Herein, we discuss the possible mechanisms of action of CP and their repercussion in COVID-19 pathogenesis, including direct neutralization of the virus, control of an overactive immune system (i.e., cytokine storm, Th1/Th17 ratio, complement activation) and immunomodulation of a hypercoagulable state. All these benefits of CP are expected to be better achieved if used in non-critically hospitalized patients, in the hope of reducing morbidity and mortality., (Copyright © 2020 The Author(s). Published by Elsevier B.V. All rights reserved.) more...
- Published
- 2020
- Full Text
- View/download PDF
5. Concurrent Guillain-Barré syndrome, transverse myelitis and encephalitis post-Zika: A case report and review of the pathogenic role of multiple arboviral immunity.
- Author
-
Mancera-Páez O, Román GC, Pardo-Turriago R, Rodríguez Y, and Anaya JM
- Subjects
- Encephalitis diagnostic imaging, Encephalitis immunology, Encephalitis therapy, Female, Guillain-Barre Syndrome diagnostic imaging, Guillain-Barre Syndrome immunology, Guillain-Barre Syndrome therapy, Humans, Immunity, Active, Myelitis, Transverse diagnostic imaging, Myelitis, Transverse immunology, Myelitis, Transverse therapy, Young Adult, Zika Virus Infection diagnostic imaging, Zika Virus Infection immunology, Zika Virus Infection therapy, Encephalitis complications, Guillain-Barre Syndrome complications, Myelitis, Transverse complications, Zika Virus Infection complications
- Abstract
We review post-infectious and post-vaccination neurological syndromes involving peripheral and central nervous system (CNS) and report an illustrative case of simultaneous occurrence of Guillain-Barré syndrome (GBS), confirmed by nerve conduction velocities, plus MRI-demonstrated transverse myelitis (TM) and acute encephalitis [acute disseminated encephalomyelitis] (ADEM+GBS) affecting a 24-year-old woman from Cúcuta, Colombia, who developed acute Zika virus (ZIKV) infection confirmed by serum reverse transcriptase-polymerase chain reaction (RT-PCR) and convalescent ZIKV IgG antibodies. With intensive care treatment, respiratory support, steroids, and intravenous immunoglobulin (IVIg), patient survived with residual flaccid paraparesis. She had preexisting immunity against Chikungunya virus (CHIKV) and Dengue virus (DENV) acquired before the arrival of ZIKV in Colombia. From reports in the Caribbean, Central and South America we review 19 cases of ZIKV-associated TM, encephalitis and ADEM occurring after a mean latent period of 10.5 days (range 1-96) post-infection. Although GBS and ADEM are usually considered post-infectious and associated with development of antibodies against peripheral nerve and CNS epitopes, we postulate that our case of ADEM+GBS is para-infectious, induced by acute ZIKV neurotropism boosted by active immunity against other arboviruses. Animal models of ZIKV demonstrated strong viral neurotropism enhanced by passive immunity with antibodies against arboviruses such as West Nile virus, CHIKV, or DENV. These considerations are relevant to prevent potential ZIKV vaccine-induced reactions involving central and peripheral nervous system., (Copyright © 2018 The Authors. Published by Elsevier B.V. All rights reserved.) more...
- Published
- 2018
- Full Text
- View/download PDF
6. Erratum to 'Concurrent Guillain-Barré syndrome, transverse myelitis and encephalitis post-Zika: A case report and review of the pathogenic role of multiple arboviral immunity', Journal of the Neurological Sciences, Volume 395, 15 December 2018, Pages 47-53.
- Author
-
Mancera-Páez O, Román GC, Pardo-Turriago R, Rodríguez Y, and Anaya JM
- Published
- 2018
- Full Text
- View/download PDF
7. Zika virus and autoimmunity. One-step forward.
- Author
-
Monsalve DM, Pacheco Y, Acosta-Ampudia Y, Rodríguez Y, Ramírez-Santana C, and Anaya JM
- Subjects
- Guillain-Barre Syndrome immunology, Humans, Molecular Mimicry, Purpura, Thrombocytopenic, Idiopathic immunology, Zika Virus Infection immunology, Autoimmunity, Guillain-Barre Syndrome etiology, Purpura, Thrombocytopenic, Idiopathic etiology, Zika Virus Infection complications
- Abstract
Zika virus (ZIKV) infection has been associated with the development of Guillain-Barré syndrome (GBS) and idiopathic thrombocytopenic purpura (ITP). Whether ZIKV infection is related to other autoimmune diseases is unknown. Therefore, an association study to evaluate rheumatic and thyroid autoimmunity in patients with ZIKV disease was conducted through a panel of 14 autoantibodies. In addition, a literature review on ZIKV, and GBS and ITP was performed. Our results disclosed a lack of association of rheumatoid and thyroid autoimmunity with ZIKV disease. A total of 272 cases of GBS related to ZIKV were retrieved from the literature, the majority of them being males (54.8%). Electrophysiological findings indicated acute inflammatory demyelinating polyneuropathy as the most frequent subphenotype (75.7%). Up to date, twenty-four cases of ITP in patients with ZIKV disease have been published. Although a few fatal cases have been observed, most of the reported patients responded well to immunomodulatory treatment. A review of the mechanisms incriminated into the development of autoimmune phenomenon in ZIKV disease indicates molecular mimicry as the most plausible one. Nevertheless, more research aimed at deciphering ZIKV disease pathogenesis and its relationship with autoimmunity is warranted., (Copyright © 2017 Elsevier B.V. All rights reserved.) more...
- Published
- 2017
- Full Text
- View/download PDF
8. Autoimmunity in Guillain-Barré syndrome associated with Zika virus infection and beyond.
- Author
-
Pinto-Díaz CA, Rodríguez Y, Monsalve DM, Acosta-Ampudia Y, Molano-González N, Anaya JM, and Ramírez-Santana C
- Subjects
- Humans, Retrospective Studies, Autoimmunity genetics, Guillain-Barre Syndrome epidemiology, Zika Virus Infection complications
- Abstract
Autoimmune diseases share common immunopathogenic mechanisms (i.e., the autoimmune tautology), which explain the clinical similarities among them as well as their familial clustering. Guillain-Barré syndrome (GBS), an autoimmune peripheral neuropathy, has been recently associated with Zika virus (ZIKV) infection. Based on a series of cases, this review article provides a comparative analysis of GBS associated with ZIKV infection, contrasted with the general characteristics of GBS in light of the autoimmune tautology, including gender differences in prevalence, subphenotypes, polyautoimmunity, familial autoimmunity, age at onset, pathophysiology, ecology, genetics, ancestry, and treatment., (Copyright © 2017 Elsevier B.V. All rights reserved.) more...
- Published
- 2017
- Full Text
- View/download PDF
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.